Apyx Medical Corp: 10-Q filed 2026-08-06
What Apyx Medical Corp reported in its quarterly report filed 2026-08-06 (fiscal Q2 2026): 47 published measures, 129 facts as tagged in accession 0001437749-26-026346.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2026-08-06
- Fiscal period
- fiscal Q2 2026
- Accession
- 0001437749-26-026346 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Apyx Medical Corp filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 61,072,000 | USD | |
| At 2025-12-31 | 66,840,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 49,982,000 | USD | |
| At 2025-12-31 | 52,009,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 10,663,000 | USD | |
| At 2025-12-31 | 14,540,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 27,617,000 | USD | |
| At 2025-12-31 | 31,740,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -3,243,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | -5,351,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | -3,778,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -7,928,000 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | -4,062,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | -1,935,000 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | 126,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | 320,000 | USD | 181 |
Contract revenue excluding tax
Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 13,884,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | 26,374,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | 11,373,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 20,803,000 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | 78,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | 50,000 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | -126,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | -320,000 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | -94,473,000 | USD | |
| At 2025-12-31 | -89,122,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 43,850,000 | shares | 91 |
| 2026-01-01 to 2026-06-30 | 43,796,000 | shares | 181 |
| 2025-04-01 to 2025-06-30 | 40,729,000 | shares | 91 |
| 2025-01-01 to 2025-06-30 | 40,729,000 | shares | 181 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -0.07 | USD/shares | 91 |
| 2026-01-01 to 2026-06-30 | -0.12 | USD/shares | 181 |
| 2025-04-01 to 2025-06-30 | -0.09 | USD/shares | 91 |
| 2025-01-01 to 2025-06-30 | -0.19 | USD/shares | 181 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 124,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | 267,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | 49,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 98,000 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 2,110,000 | USD | |
| At 2025-12-31 | 2,371,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | 1,386,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | 971,000 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -1,806,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | -2,717,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | -2,574,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -5,625,000 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 53,155,000 | USD | |
| At 2025-12-31 | 58,471,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 9,354,000 | USD | |
| At 2025-12-31 | 11,700,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 2,190,000 | USD | |
| At 2025-12-31 | 3,058,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 13,614,000 | USD | |
| At 2025-12-31 | 16,776,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 10,676,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | 19,512,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | 9,657,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 18,373,000 | USD | 181 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 10,747,000 | USD | |
| At 2025-12-31 | 8,602,000 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 8,870,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | 16,795,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | 7,083,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 12,748,000 | USD | 181 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 5,285,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | 8,861,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | 4,265,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 7,731,000 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 793,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | 1,558,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | 824,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 1,628,000 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 42,116,330 | shares | |
| At 2025-12-31 | 41,785,946 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 105,094,000 | USD | |
| At 2025-12-31 | 103,620,000 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 11,090,000 | USD | |
| At 2026-03-31 | 13,088,000 | USD | |
| At 2025-12-31 | 14,831,000 | USD | |
| At 2025-06-30 | 7,456,000 | USD | |
| At 2025-03-31 | 10,644,000 | USD | |
| At 2024-12-31 | 14,335,000 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 4,014,000 | USD | |
| At 2025-12-31 | 4,218,000 | USD |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 37,500,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 4,519,000 | USD | |
| At 2025-12-31 | 4,293,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 1,776,000 | USD | |
| At 2025-12-31 | 1,752,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 336,000 | USD | |
| At 2025-12-31 | 347,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 6,692,000 | USD | |
| At 2025-12-31 | 8,214,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 1,177,000 | USD | |
| At 2025-12-31 | 1,353,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -2,948,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | -4,948,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | -3,689,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -7,812,000 | USD | 181 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -3,072,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | -5,215,000 | USD | 181 |
| 2026-01-01 to 2026-03-31 | -2,143,000 | USD | 90 |
| 2025-04-01 to 2025-06-30 | -3,738,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -7,910,000 | USD | 181 |
| 2025-01-01 to 2025-03-31 | -4,172,000 | USD | 90 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -3,243,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | -5,351,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | -3,778,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -7,928,000 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | 398,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | 270,000 | USD | 181 |
Nonoperating interest expense
Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 1,394,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | 2,763,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | 1,393,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 2,769,000 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -1,142,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | -2,231,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | -1,115,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -2,187,000 | USD | 181 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | 2,284,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | 2,300,000 | USD | 181 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | 166,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | 76,000 | USD | 181 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | -3,006,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | -4,413,000 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | 2,156,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | 720,000 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | -855,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | 182,000 | USD | 181 |
Inspect the source
- Entity
- Apyx Medical Corp / CIK 0000719135
- Captured
- 2026-09-19T14:59:27.679Z
- SEC response SHA-256
1ad7c3d4dfc962b193500ee95296522ecc0d30e02ab691d084b6fdfa682a7b5a
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000719135.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))